Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENETIC TECHNOLOGIES LIMITED Regulatory Filings 2021

Nov 8, 2021

65022_rns_2021-11-08_d94ee5d4-f20f-4d86-accc-ab6dc1bbe708.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [110 x 70] intentionally omitted <==

Jobkeeper s323DB Notice

Melbourne, Australia, 9 November 2021: Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness and serious disease, provides the appended notice in accordance with subsection 323DB(1) of the Corporations Act 2001 (Cth).

Authorised for release by the Board of Genetic Technologies Limited.

-END-

Investor Relations (AUS)

Investor Relations and Media (US)

Stephanie Ottens Dave Gentry Market Eye 1 800 RED CHIP (733 2447) M: +61 434 405 400 Cell: 407 491 4498 E: [email protected] E: [email protected]

About Genetic Technologies Limited

Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) is a diversified molecular diagnostics company. GTG offers cancer predictive testing and assessment tools to help physicians proactively manage patient health. The Company’s lead products GeneType for Breast Cancer for non-hereditary breast cancer and GeneType for Colorectal Cancer are clinically validated risk assessment tests and are first in class. Genetic Technologies is developing a pipeline of risk assessment products.

For more information, please visit www.gtglabs.com

Genetic Technologies Limited 60-66 Hanover Street www.gtglabs.com Fitzroy Victoria 3065 [email protected] Australia ABN 17 009 212 328 +61 3 8412 7000

Jobkeeper Payments Notification

A notice for release to the market under subsection 323DB(1) of the Corporations Act 2001jobkeeper payments disclosure by listed entity.

Date of this notice

08/11/2021

Listed entity details

Australian Business Number (ABN) ASX/NSX/SSX issuer code 17009212328 GTG Name of the listed entity Genetic Technologies Limited

Jobkeeper payments

This notice relates to the financial years ended 30/06/2020 (FY 1) and 30/06/2021 (FY 2).

The number of individuals for whom the listed entity or a subsidiary of the listed entity received a jobkeeper payment for a jobkeeper fortnight that ended in the financial year (within the meaning of the Coronavirus Economic Response Package (Payments and Benefits) Rules 2020).

FY 1: 15 FY 2: 15

The sum of all jobkeeper payments the listed entity, and each subsidiary of the listed entity, received in a jobkeeper fortnight that ended in the financial year.

FY 1: $135,000 FY 2: $157,500

Has the listed entity or a subsidiary of the listed entity, made one or more voluntary payments (whether or not in the financial year) to the Commonwealth by way of a repayment of jobkeeper payments received by the listed entity or a subsidiary of the listed in the financial year?

NO

If the listed entity or a subsidiary of the listed entity has made such a voluntary payment or payments –the sum of those payments:

FY 1:$0

FY 2:$0